{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T15:40:06Z","timestamp":1756395606323,"version":"3.44.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Abemaciclib is approved for adjuvant use in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. Its toxicity profile is derived from studies favoring patients undergoing breast conservation therapy. This study investigates the impact of abemaciclib on wound complications in the setting of postmastectomy radiation therapy (PMRT) and implant-based reconstruction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A single-center, retrospective chart review was conducted. Patients who underwent mastectomy, implant-based reconstruction, and PMRT between January 2020 and December 2022 were included. Descriptive statistics characterized the study population and determined rates of any complication, major complications requiring reoperation, and complications by subtype (contracture, extrusion, tissue expander changes, infection, seroma, dermatitis, and pain). \u03c7<jats:sup>2<\/jats:sup> and the Fisher Exact tests assessed associations between abemaciclib use, complications, and potential risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seventy-five patients were included. Fifteen underwent adjuvant abemaciclib therapy. Thirty-four patients (45.3%) were obese (BMI \u226530), 24 (32.0%) had a smoking history, and 4 (5.3%) had diabetes. The incidences of any complication and major complications were 33.3% and 17.5%, respectively. There was no significant association between abemaciclib use and any complication (<jats:italic toggle=\"yes\">P<\/jats:italic>=1.000), major complications (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.729), or any complication subtype (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.865). There was a significant association between BMI and any complication (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.014).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The study suggests that the use of adjuvant abemaciclib is not associated with an increased risk of postradiation reconstructive complications in patients undergoing implant-based reconstruction. Continued surveillance of complications associated with abemaciclib is warranted with a larger sample size.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000001186","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:01:26Z","timestamp":1741132886000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Complications of Implant-Based Reconstruction and Postmastectomy Radiation in the Era of Adjuvant CDK4\/6 Inhibitors"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-3845","authenticated-orcid":false,"given":"Hamail","family":"Iqbal","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badal","family":"Juneja","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Chryssofos","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Cooper Medical School of Rowan University, Cooper University Health Care, Camden, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuti","family":"Ahlawat","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Bonawitz","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Cooper Medical School of Rowan University, Cooper University Health Care, Camden, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Leilani","family":"Fahey","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Cooper Medical School of Rowan University, Cooper University Health Care, Camden, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Loveland-Jones","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, Cooper Medical School of Rowan University, MD Anderson Cancer Center at Cooper University Health Care"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Steinmetz","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, Cooper Medical School of Rowan University, MD Anderson Cancer Center at Cooper University Health Care"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Markabawi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Kurian","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony E.","family":"Dragun","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"R1-20250828","first-page":"721","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","volume":"15","author":"Wang","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"R2-20250828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/abs-23-33","article-title":"The psychological impacts of post-mastectomy breast reconstruction: a systematic review","volume":"8","author":"Roy","year":"2024","journal-title":"Ann Breast Surg"},{"key":"R3-20250828","doi-asserted-by":"crossref","first-page":"e4179","DOI":"10.1097\/GOX.0000000000004179","article-title":"Implant-based breast reconstruction after mastectomy for breast cancer: a systematic review and meta-analysis","volume":"10","author":"Saldanha","year":"2022","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R4-20250828","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.SAP.0000041488.88950.A2","article-title":"Impact of immediate reconstruction on the local recurrence of breast cancer after mastectomy","volume":"50","author":"Murphy","year":"2003","journal-title":"Ann Plast Surg"},{"key":"R5-20250828","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bjps.2017.05.057","article-title":"Determining the outcomes of post-mastectomy radiation therapy delivered to the definitive implant in patients undergoing one- and two-stage implant-based breast reconstruction: a systematic review and meta-analysis","volume":"70","author":"Magill","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R6-20250828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SAP.0000000000001186","article-title":"Complications after total skin-sparing mastectomy and expander-implant reconstruction: effects of radiation therapy on the stages of reconstruction","volume":"80","author":"Peled","year":"2018","journal-title":"Ann Plast Surg"},{"key":"R7-20250828","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1524-4741.2011.01182.x","article-title":"Risk factors for complications of radiation therapy on tissue expander breast reconstructions","volume":"18","author":"Brooks","year":"2012","journal-title":"Breast J"},{"key":"R8-20250828","first-page":"1","article-title":"Association between body mass index and adverse surgical outcomes of implant-based breast reconstruction: a prospective cohort study of 5,545 breast reconstructions","volume":"6","author":"Goltsman","year":"2021","journal-title":"Ann Breast Surg"},{"key":"R9-20250828","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41523-021-00289-7","article-title":"Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups","volume":"7","author":"Johnston","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"R10-20250828","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11912-019-0769-3","article-title":"CDK 4\/6 inhibitors in breast cancer: current controversies and future directions","volume":"21","author":"Spring","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"R11-20250828","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.20.02514","article-title":"Abemaciclib Combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer (MONARCHE)","volume":"38","author":"Johnston","year":"2020","journal-title":"J Clin Oncol"},{"key":"R12-20250828","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","article-title":"MONARCH 3: abemaciclib as initial therapy for advanced breast cancer","volume":"35","author":"Goetz","year":"2017","journal-title":"J Clin Oncol"},{"key":"R13-20250828","doi-asserted-by":"crossref","first-page":"1758835918793326","DOI":"10.1177\/1758835918793326","article-title":"Management of adverse events during cyclin-dependent kinase 4\/6 (CDK4\/6) inhibitor-based treatment in breast cancer","volume":"10","author":"Thill","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"R14-20250828","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.seminoncol.2018.01.006","article-title":"Mechanisms of therapeutic CDK4\/6 inhibition in breast cancer","volume":"44","author":"Scott","year":"2017","journal-title":"Semin Oncol"},{"key":"R15-20250828","doi-asserted-by":"crossref","first-page":"e974","DOI":"10.1097\/SLA.0000000000003670","article-title":"Postmastectomy radiation therapy on permanent implants or tissue expanders: which is better?","volume":"274","author":"Lin","year":"2021","journal-title":"Ann Surg"},{"key":"R16-20250828","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PRS.0000000000002534","article-title":"Postmastectomy radiation therapy and two-stage implant-based breast reconstruction: is there a better time to irradiate?","volume":"138","author":"Santosa","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R17-20250828","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SLA.0000000000001177","article-title":"Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis","volume":"263","author":"Jagsi","year":"2016","journal-title":"Ann Surg"},{"key":"R18-20250828","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PRS.0000000000010824","article-title":"Modifiable postmastectomy radiation therapy factors and impact on implant-based breast reconstruction outcomes","volume":"153","author":"Barnes","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"R19-20250828","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/tbj.13434","article-title":"Operative risk stratification in the obese female undergoing implant-based breast reconstruction","volume":"25","author":"Rudolph","year":"2019","journal-title":"Breast J"},{"key":"R20-20250828","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1097\/PRS.0b013e3181bf80aa","article-title":"Independent risk factors for infection in tissue expander breast reconstruction","volume":"124","author":"Francis","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R21-20250828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/SAP.0b013e318276d91d","article-title":"Body mass index as a continuous predictor of outcomes after expander-implant breast reconstruction","volume":"73","author":"Nguyen","year":"2014","journal-title":"Ann Plast Surg"},{"key":"R22-20250828","doi-asserted-by":"crossref","first-page":"245e","DOI":"10.1097\/PRS.0000000000000912","article-title":"Assessment of patient factors, surgeons, and surgeon teams in immediate implant-based breast reconstruction outcomes","volume":"135","author":"Gfrerer","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R23-20250828","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/PRS.0b013e31817151c4","article-title":"Predicting complications following expander\/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk","volume":"121","author":"McCarthy","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"R24-20250828","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archsurg.2012.5","article-title":"Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis","volume":"147","author":"S\u00f8rensen","year":"2012","journal-title":"Arch Surg"},{"key":"R25-20250828","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1097\/SLA.0000000000005574","article-title":"The timing of acute and late complications following mastectomy and implant-based reconstruction","volume":"278","author":"Jimenez","year":"2023","journal-title":"Ann Surg"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T15:00:35Z","timestamp":1756393235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000001186","relation":{},"ISSN":["0277-3732","1537-453X"],"issn-type":[{"type":"print","value":"0277-3732"},{"type":"electronic","value":"1537-453X"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}